At a glance
ClinicalIndex Comparison RecordN/ACompleted· 139 enrolled
Drug / intervention
Nicotine Replacement Therapy +1 moredrug
Likely dose
Not stated in record
Key inclusion· 3
- ✓Current smoker of at least 5 cigarettes per day, or quit within the last 6 weeks
- ✓Pre-hypertensive or Stage I hypertension: systolic BP 120–159 and/or diastolic BP 80–99 mm Hg; or on antihypertensives with BP <160/100 mm Hg
- ✓Access to a telephone
Key exclusion· 17
- ✕Unstable cardiovascular disease, myocardial infarction, stroke, or unstable angina within 3 months
- ✕Coronary artery bypass grafting or angioplasty/stent within 3 months
- ✕Cardiac dysrhythmia treated with anti-arrhythmia medication (except stable atrial fibrillation)
- ✕Untreated hyperthyroidism or pheochromocytoma
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Blood Pressure Control in Hypertensive Smokers
In Brief
A clinical study evaluating Nicotine Replacement Therapy and Diet for Cardiovascular Diseases and 2 related conditions. Completed, enrolled 139 participants across 2 sites.
Detailed Summary
The purpose of this study is to develop effective interventions that assist individuals with high blood pressure to quit smoking and prevent weight gain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Hypertension
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2004
First PostedJun 2005
Primary CompletionJun 2011
TodayJul 2026
First PostedJun 6, 2005
Enrollment StartSep 1, 2004
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6.8 yearsPosted 21.1 years ago
Interventions
Nicotine Replacement Therapydrug
Nicotine replacement therapy program
Dietbehavioral
Diet program